Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Cancer-related Problem/Condition: early-phase trial registry
1 of 11 indexed Cancer-related Problem/Condition trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 1 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Cancer-related Problem/Condition: 11 US clinical trials tracked, 1 recruiting.
Cancer-related Problem/Condition is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Icahn School of Medicine at Mount Sinai, running 2 of these trials.
Enrollment posture brief
Registry condition cancer-related-problemcondition
OPEN 1 | RECR 9% | LATE 0 | EARLY 1 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Cancers (9% recruiting · 11 trials)
Cancer-related Problem/Condition lists 1 open slots (9% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Cancer-related Problem/Condition on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Cancer-related Problem/Condition is recruiting below its size-band peers.
1 of 11 indexed trials (9.1%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Cancer-related Problem/Condition research.
Icahn School of Medicine at Mount Sinai accounts for 2 of 11 trials (18.2%). 10 distinct sponsors appear on at least one study for this condition label.
-
Most Cancer-related Problem/Condition trials plan to enrol fewer than 100 people.
Median target enrolment is 72 among the 11 trials that report a genuine target (sentinel values excluded). 7 of those (63.6%) plan for fewer than 100 participants.
-
Cancer-related Problem/Condition research is mostly interventional.
11 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors
5 Point App
NCT06754722
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
Abramson Cancer Center at Penn Medicine
NCT05226078
Virtual Exercise Program to Reduce Cancer Related Fatigue
University of Colorado, Denver
NCT04533165
The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study
American Cancer Society
NCT03345264
Systematic Light Exposure for Fatigue in Breast Cancer Patients
Icahn School of Medicine at Mount Sinai
NCT03217201
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NCT03576274
Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue
Icahn School of Medicine at Mount Sinai
NCT03198754
Memory and Attention Adaptation Training-Geriatrics (MAAT-G) Phase II
University of Rochester
NCT04669301
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
Virginia Commonwealth University
NCT01196442
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Yvan Beaussant, MD, MSci
NCT04950608
Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients
Maureen T Greene
NCT01967836
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Cancer-related Problem/Condition records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Cancer-related Problem/Condition trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Cancer-related Problem/Condition page
11 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Cancer-related Problem/Condition trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Icahn School of Medicine at Mount Sinai sponsors the most Cancer-related Problem/Condition trials on record, review their full trial history before evaluating a specific study. See Icahn School of Medicine at Mount Sinai's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cancer-related Problem/Condition condition card totals 11 registered trials; most-linked intervention Supportive therapy (time and attention control); top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.